Unlock instant, AI-driven research and patent intelligence for your innovation.
Citric acid hemodialysis concentrate for supplementing vitamin D
What is Al technical title?
Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A technology for vitamin supplementation and hemodialysis, which is applied in the field of citrate hemodialysis concentrate to achieve high survival rate and prevent loss.
Inactive Publication Date: 2020-08-18
甘肃锦东医疗器械有限公司
View PDF5 Cites 0 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
[0013] At present, the methods of clinically supplementing vitamin D are mainly oral vitamin D capsules and intravenous vitamin D injections. There are no other methods and products for supplementing vitamin D, and there is no special method of hemodialysis for the treatment of mineral and bone metabolism disorders and Its complications, especially the citrate hemodialysis concentrate formula and products supplemented with vitamin D in chronic kidneydisease patients with diabetes are still blank
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Image
Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
Click on the blue label to locate the original text in one second.
Reading with bidirectional positioning of images and text.
[0035] Dialysate side: the formula of the dialysis concentrate is selected from the formula of Example 1 in Table 4, wherein the pH regulator is citric acid, and is prepared after dilution according to A:B:water=1:1.225:32.775 The hemodialysate, the ion concentration in the hemodialysate is as shown in Table 5:
[0036] Ion concentration and pH value in dialysate after dilution in Table 5 Example 1
[0037]
[0038] (2) After dialysis
[0039] The content of paricalcitol active vitamin D in normal saline and dialysate after dialysis was detected with an automatic biochemical analyzer, and the results are shown in Table 6.
[0040] Table 6 Vitamin D content in blood and dialysate after dialysis (unit: g / 5L)
[0041]
Embodiment 2
[0043] (1) Before dialysis:
[0044] Normal saline side: 5L normal saline, add paricalcitol active vitamin D0.15g;
[0045] Dialysate side: the formula of the dialysis concentrate is selected from the formula of Example 1 in Table 4, wherein the selected pH regulator is citric acid; and after dilution according to A:B:water=1:1.225:32.775 Prepare hemodialysate, and the ion concentration in the hemodialysate is as shown in Table 7:
[0046] Ion concentration and pH value in dialysate after dilution in Table 7 Example 2
[0047]
[0048] (2) After dialysis
[0049]The content of paricalcitol active vitamin D in normal saline and dialysate after dialysis was detected with an automatic biochemical analyzer, and the results are shown in Table 8.
[0050] Table 8 Vitamin D content in blood and dialysate after dialysis (unit: g / 5L)
[0051]
Embodiment 3
[0053] (1) Before dialysis:
[0054] Normal saline side: 5L normal saline, add paricalcitol active vitamin D0.15g;
[0055] Dialysate side: the formula of the dialysis concentrate is selected from the formula of Example 3 in Table 4, wherein the pH regulator is citric acid, and it is prepared after dilution according to A:B:water=1:1.225:32.775 The hemodialysate, the ion concentration in the hemodialysate is shown in Table 9:
[0056] Ion concentration and pH value in dialysate after dilution in table 9 embodiment 3
[0057]
[0058] (2) After dialysis
[0059] The content of Paricalcitol active vitamin D in normal saline and dialysate after dialysis was detected with an automatic biochemical analyzer, and the results are shown in Table 10.
[0060] Table 10 Vitamin D content in blood and dialysate after dialysis (unit: g / 5L)
[0061]
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More
PUM
Login to View More
Abstract
The invention belongs to the technical field of hemodialysis concentrates, and particularly relates to a concentrate obtained by supplementing palmatol active vitamin D (C27H44O3) into a citric acidhemodialysis concentrate. The content of the paracetamol active vitamin D is 0.15 to 0.30 g / 5L. The concentrate provided by the invention can be slowly perfused in a hemodialysis manner, the content ofvitamin D in the blood of a nephrotic patient is controlled within a reasonable concentration range of a human body, loss of vitamin D in the blood is prevented, vitamin D lacked by the nephrotic patient is supplemented, minerals, bone metabolism disorder and complications of the mineral substances and the bone metabolism disorder of the chronic nephrotic patient are effectively treated, and thena higher survival rate is brought to the nephrotic patient. Meanwhile, compared with oral vitamin D capsules and intravenous injection of vitamin D, the vitamin D is added into the citric acidhemodialysis concentrate and hemodialysis is carried out, so that the preparation method is an optimal way for treating mineral substances, bone metabolic disorders and complications thereof of patients with chronic kidney diseases at present.
Description
technical field [0001] The invention belongs to the technical field of hemodialysis concentrates, in particular to a citric acidhemodialysis concentrate supplemented with vitamin D. Background technique [0002] Hemodialysis uses artificial methods to imitate the filtering function of the human kidney. Under the condition of extracorporeal circulation, it removes excess nitrogen-containing compounds, metabolic products or excess drugs and other toxic substances in the human blood, and adjusts the balance of water and electrolytes. Healing function. [0003] In my country, due to the limited source of kidneytransplant donors, dialysis is the main way of life maintenance and long-term treatment for patients with end-stage renal disease. [0004] In the existing dialysis treatment technology, the hemodialysate is the liquid that needs to be used for solute exchange with the blood on both sides of the dialysis membrane through diffusion during hemodialysis. It can be directly...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.
Login to View More 
Login to View More